These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21735479)

  • 1. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to low-dose quetiapine.
    Walsh RA; Lang AE
    Mov Disord; 2011 Oct; 26(12):2297-8. PubMed ID: 21735479
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment-emergent tardive dyskinesia with quetiapine in mood disorders.
    Sharma V
    J Clin Psychopharmacol; 2003 Aug; 23(4):415-7. PubMed ID: 12920421
    [No Abstract]   [Full Text] [Related]  

  • 3. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible withdrawal dyskinesia associated with quetiapine.
    Michaelides C; Thakore-James M; Durso R
    Mov Disord; 2005 Jun; 20(6):769-70. PubMed ID: 15747370
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine induced tardive dyskinesia treated successfully with quetiapine: a case report.
    Ugurlu GK; Tufan E; Bilici R; Ugurlu M; Saglam S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):276-7. PubMed ID: 20868719
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ; Reimer J; Wiedemann K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oropharyngeal and facial dyskinesia after discontinuation of quetiapine.
    Kruger TH; Horvath A; Schnieber M; Seifritz E
    J Clin Psychopharmacol; 2008 Dec; 28(6):705-6. PubMed ID: 19011443
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine.
    Bouckaert F; Herman G; Peuskens J
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):287-8. PubMed ID: 15770692
    [No Abstract]   [Full Text] [Related]  

  • 9. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine.
    Himmerich H; Ehrlinger M; Hackenberg M; Löhr B; Nickel T
    J Clin Psychopharmacol; 2006 Dec; 26(6):676-7. PubMed ID: 17110835
    [No Abstract]   [Full Text] [Related]  

  • 11. Quetiapine-associated dysphagia.
    Kohen I; Lester P
    World J Biol Psychiatry; 2009; 10(4 Pt 2):623-5. PubMed ID: 18615368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical neuroleptic malignant syndrome with quetiapine: a case report and review of the literature.
    El-Gaaly S; St John P; Dunsmore S; Bolton JM
    J Clin Psychopharmacol; 2009 Oct; 29(5):497-9. PubMed ID: 19745653
    [No Abstract]   [Full Text] [Related]  

  • 13. Very low dose quetiapine-induced galactorrhea in combination with venlafaxine.
    Pae CU; Kim JJ; Lee CU; Chae JH; Lee SJ; Lee C; Paik IH
    Hum Psychopharmacol; 2004 Aug; 19(6):433-4. PubMed ID: 15303249
    [No Abstract]   [Full Text] [Related]  

  • 14. Side effects of antipsychotics in the elderly.
    Masand PS
    J Clin Psychiatry; 2000; 61 Suppl 8():43-9; discussion 50-1. PubMed ID: 10811243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome associated with quetiapine.
    al-Waneen R
    Can J Psychiatry; 2000 Oct; 45(8):764-5. PubMed ID: 11086565
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting.
    Ketter TA; Brooks JO; Hoblyn JC; Holland AA; Nam JY; Culver JL; Marsh WK; Bonner JC
    J Psychiatr Res; 2010 Oct; 44(14):921-9. PubMed ID: 20378127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
    Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R
    J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intolerable fever: a previously unreported side-effect of quetiapine.
    Gutman S; Layland J
    Aust N Z J Psychiatry; 2012 Jan; 46(1):72-3. PubMed ID: 22247102
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient tardive dystonia: overview and case presentation.
    Seeman MV; Clodman D; Remington G
    J Psychiatr Pract; 2008 Jul; 14(4):251-7. PubMed ID: 18664896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia and depressive illness.
    Davis KL; Berger PA; Hollister LE
    Psychopharmacol Commun; 1976; 2(2):125-30. PubMed ID: 10603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.